A sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy.

Duchenne muscular dystrophy (DMD) is characterized by the absence or reduced levels of dystrophin expression on the inner surface of the sarcolemmal membrane of muscle fibers. Clinical development of therapeutic approaches aiming to increase dystrophin levels requires sensitive and reproducible meas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chantal Beekman, Jessica A Sipkens, Janwillem Testerink, Stavros Giannakopoulos, Dyonne Kreuger, Judith C van Deutekom, Giles V Campion, Sjef J de Kimpe, Afrodite Lourbakos
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cd13d08f1d8d4544abd4ec444d29d804
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cd13d08f1d8d4544abd4ec444d29d804
record_format dspace
spelling oai:doaj.org-article:cd13d08f1d8d4544abd4ec444d29d8042021-11-25T05:59:51ZA sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy.1932-620310.1371/journal.pone.0107494https://doaj.org/article/cd13d08f1d8d4544abd4ec444d29d8042014-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0107494https://doaj.org/toc/1932-6203Duchenne muscular dystrophy (DMD) is characterized by the absence or reduced levels of dystrophin expression on the inner surface of the sarcolemmal membrane of muscle fibers. Clinical development of therapeutic approaches aiming to increase dystrophin levels requires sensitive and reproducible measurement of differences in dystrophin expression in muscle biopsies of treated patients with DMD. This, however, poses a technical challenge due to intra- and inter-donor variance in the occurrence of revertant fibers and low trace dystrophin expression throughout the biopsies. We have developed an immunofluorescence and semi-automated image analysis method that measures the sarcolemmal dystrophin intensity per individual fiber for the entire fiber population in a muscle biopsy. Cross-sections of muscle co-stained for dystrophin and spectrin have been imaged by confocal microscopy, and image analysis was performed using Definiens software. Dystrophin intensity has been measured in the sarcolemmal mask of spectrin for each individual muscle fiber and multiple membrane intensity parameters (mean, maximum, quantiles per fiber) were calculated. A histogram can depict the distribution of dystrophin intensities for the fiber population in the biopsy. This method was tested by measuring dystrophin in DMD, Becker muscular dystrophy, and healthy muscle samples. Analysis of duplicate or quadruplicate sections of DMD biopsies on the same or multiple days, by different operators, or using different antibodies, was shown to be objective and reproducible (inter-assay precision, CV 2-17% and intra-assay precision, CV 2-10%). Moreover, the method was sufficiently sensitive to detect consistently small differences in dystrophin between two biopsies from a patient with DMD before and after treatment with an investigational compound.Chantal BeekmanJessica A SipkensJanwillem TesterinkStavros GiannakopoulosDyonne KreugerJudith C van DeutekomGiles V CampionSjef J de KimpeAfrodite LourbakosPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 9, p e107494 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Chantal Beekman
Jessica A Sipkens
Janwillem Testerink
Stavros Giannakopoulos
Dyonne Kreuger
Judith C van Deutekom
Giles V Campion
Sjef J de Kimpe
Afrodite Lourbakos
A sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy.
description Duchenne muscular dystrophy (DMD) is characterized by the absence or reduced levels of dystrophin expression on the inner surface of the sarcolemmal membrane of muscle fibers. Clinical development of therapeutic approaches aiming to increase dystrophin levels requires sensitive and reproducible measurement of differences in dystrophin expression in muscle biopsies of treated patients with DMD. This, however, poses a technical challenge due to intra- and inter-donor variance in the occurrence of revertant fibers and low trace dystrophin expression throughout the biopsies. We have developed an immunofluorescence and semi-automated image analysis method that measures the sarcolemmal dystrophin intensity per individual fiber for the entire fiber population in a muscle biopsy. Cross-sections of muscle co-stained for dystrophin and spectrin have been imaged by confocal microscopy, and image analysis was performed using Definiens software. Dystrophin intensity has been measured in the sarcolemmal mask of spectrin for each individual muscle fiber and multiple membrane intensity parameters (mean, maximum, quantiles per fiber) were calculated. A histogram can depict the distribution of dystrophin intensities for the fiber population in the biopsy. This method was tested by measuring dystrophin in DMD, Becker muscular dystrophy, and healthy muscle samples. Analysis of duplicate or quadruplicate sections of DMD biopsies on the same or multiple days, by different operators, or using different antibodies, was shown to be objective and reproducible (inter-assay precision, CV 2-17% and intra-assay precision, CV 2-10%). Moreover, the method was sufficiently sensitive to detect consistently small differences in dystrophin between two biopsies from a patient with DMD before and after treatment with an investigational compound.
format article
author Chantal Beekman
Jessica A Sipkens
Janwillem Testerink
Stavros Giannakopoulos
Dyonne Kreuger
Judith C van Deutekom
Giles V Campion
Sjef J de Kimpe
Afrodite Lourbakos
author_facet Chantal Beekman
Jessica A Sipkens
Janwillem Testerink
Stavros Giannakopoulos
Dyonne Kreuger
Judith C van Deutekom
Giles V Campion
Sjef J de Kimpe
Afrodite Lourbakos
author_sort Chantal Beekman
title A sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy.
title_short A sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy.
title_full A sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy.
title_fullStr A sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy.
title_full_unstemmed A sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy.
title_sort sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/cd13d08f1d8d4544abd4ec444d29d804
work_keys_str_mv AT chantalbeekman asensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT jessicaasipkens asensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT janwillemtesterink asensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT stavrosgiannakopoulos asensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT dyonnekreuger asensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT judithcvandeutekom asensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT gilesvcampion asensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT sjefjdekimpe asensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT afroditelourbakos asensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT chantalbeekman sensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT jessicaasipkens sensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT janwillemtesterink sensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT stavrosgiannakopoulos sensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT dyonnekreuger sensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT judithcvandeutekom sensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT gilesvcampion sensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT sjefjdekimpe sensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
AT afroditelourbakos sensitivereproducibleandobjectiveimmunofluorescenceanalysismethodofdystrophininindividualfibersinsamplesfrompatientswithduchennemusculardystrophy
_version_ 1718414306903588864